Analyst Ratings for NervGen Pharma Corp (NGEN)
NGEN Rating Summary
NGEN Price Target Summary
- Highest: $18.00 (Lucid Capital Markets)
- Lowest: $12.00 (Maxim Group)
- Average: $16.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.00 (+676.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$16.00 (+676.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2026 | TD Cowen | Joseph Thome | New Coverage | Buy (N/A) |
N/A (N/A) |
1.73 (2.06) |
19.08% | Details |
| 4/27/2026 | H.C. Wainwright » Updated 4/28/2026 |
Raghuram Selvaraju | New Coverage | Buy (N/A) |
18.00 (N/A) |
3.92 (2.06) |
-47.45% | Details |
 |
||||||||
